창상 피복재 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Wound Dressing Market Size, Share & Trends Analysis Report By Product (Traditional Dressing, Advanced Dressing), By Application (Chronic Wounds, Acute Wounds), By End-use, By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

창상 피복재 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 창상 피복재 시장 규모는 2030년까지 189억 달러에 달할 것으로 추정되고 있습니다.

이 시장은 2024-2030년 4.16%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다. 만성 상처로 고통받는 사람들의 증가, 기술적으로 진보된 드레싱의 증가, 외상성 사고 사례 증가가 시장의 주요 촉진요인이 될 것으로 예상됩니다.

당뇨병과 같은 만성질환 증가로 인해 당뇨병성 족부궤양을 앓고 있는 사람들의 수가 증가하고 있습니다. 예를 들어 국제당뇨병연맹(IDF)에 따르면 유럽에 거주하는 20-79세 인구 중 약 6,100만 명이 당뇨병을 앓고 있는 것으로 추정됩니다. 마찬가지로 미국 생명공학정보센터(NCBI)에 따르면 전 세계 당뇨병성 족부 궤양 발생률은 연간 910만 명에서 2,610만 명에 달할 전망입니다. 이처럼 당뇨병 및 당뇨병성 족부궤양 환자 증가는 상처 드레싱 제품에 대한 수요를 증가시키고 있습니다.

또한 화상, 총격, 교통사고 등 외상성 사고가 전 세계에서 증가하고 있습니다. 예를 들어 2023년 10월 세계보건기구(WHO) 통계에 따르면 전 세계에서 약 1,100만 건의 화상이 발생하여 전 세계에서 18만 명이 사망했습니다. 마찬가지로 NCBI에 따르면 매일 전 세계에서 3만 건 이상의 화상 사례가 등록됩니다. 따라서 전 세계 화상 사례 증가는 예측 기간 중 시장을 자극할 것으로 예상됩니다.

창상 피복재 시장 보고서 하이라이트

• 제품별로는 고급 드레싱 분야가 2023년 시장을 장악했습니다. 이는 전 세계에서 외상성 사고가 증가하고 있기 때문입니다.
• 용도별로는 만성 상처 분야가 2023년 시장을 독점했습니다.
• 최종 용도별로는 병원 부문이 2023년 시장을 주도했습니다. 이는 외과수술 증가와 병원 수 증가로 인한 것으로 보입니다.
• 북미가 2023년 시장을 장악했습니다. 이러한 우위는 잘 갖춰진 의료 인프라, 높은 인지도, 그리고 이 지역의 주요 기업의 존재에 기인합니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 창상 피복재 시장 변수, 동향, 범위

• 시장 계통 전망
  • 모시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 촉진요인 분석
  • 시장 억제요인 분석
• 창상 피복재 시장 분석 툴
  • 업계 분석 - Porter의 산업 분석
  • PESTEL 분석

제4장 창상 피복재 시장 : 제품 추정·동향 분석

• 정의와 범위
  • 첨단 피복재
  • 기존 피복재
• 제품 시장 점유율, 2023년과 2030년
• 부문 대시보드
• 제품별 세계의 창상 피복재 시장 전망
• 이하 시장 규모, 예측 및 동향 분석, 2018-2030년
  • 기존 피복재
  • 첨단 피복재

제5장 창상 피복재 시장 : 용도 추정·동향 분석

• 정의와 범위
  • 만성 창상
  • 급성 창상
• 용도 시장 점유율, 2023년과 2030년
• 부문 대시보드
• 용도별 세계의 창상 피복재 시장 전망
• 이하 시장 규모, 예측 및 동향 분석, 2018-2030년
  • 만성 창상
  • 급성 창상

제6장 창상 피복재 시장 : 최종 용도 추정·동향 분석

• 정의와 범위
  • 병원
  • 외래 시설
  • 홈헬스케어
  • 연구·제조
• 최종 용도 시장 점유율, 2023년 및 2030년
• 부문 대시보드
• 최종 용도별 세계의 창상 피복재 시장 전망
• 이하 시장 규모, 예측 및 동향 분석, 2018-2030년
  • 병원
  • 외래 시설
  • 홈헬스케어
  • 연구·제조

제7장 창상 피복재 시장 : 지역 추정·동향 분석

• 지역 시장 점유율 분석, 2023년 및 2030년
• 지역 시장 대시보드
• 세계의 지역 시장 스냅숏
• 시장 규모와 예측 동향 분석, 2018-2030년 :
• 북미
  • 시장 추산·예측, 2018-2030년
  • 미국
  • 캐나다
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 인도
  • 중국
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제8장 경쟁 구도

• 주요 시장 참여 기업에 의한 최근 동향과 영향 분석
• 회사/경쟁 분류
  • 이노베이터
• 벤더 구도
  • List of key distributors and channel partners
  • Key customers
  • Key company market share analysis
  • Smith+Nephew
  • Molnlycke Health Care AB
  • Convatec Group PLC
  • Ethicon(Johnson &Johnson)
  • URGO
  • Coloplast Corp.
  • 3M
  • Integra LifeSciences
  • PAUL HARTMANN AG
  • Dr. Ausbuttel &Co. GmbH
  • Medline Industries, Inc.
  • Brightwake Ltd.

KSA

영문 목차

영문목차

Wound Dressing Market Growth & Trends:

The global wound dressing market size is estimated to reach USD 18.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 4.16% from 2024 to 2030. An increasing number of people suffering from chronic wounds, a rise in technologically advanced dressing, and rising cases of traumatic accidents are expected to be the key driving factors for the market.

The number of people suffering from diabetic foot ulcers is increasing, due to a rise in chronic disorders like diabetes. For instance, as per the International Diabetes Federation (IDF), an estimated population of 61 million people aged between 20-79 years living in Europe were suffering from diabetes. Similarly, according to the National Center for Biotechnology Information (NCBI), the incidence rate of diabetes foot ulcers globally is between 9.1 million to 26.1 million annually. Thus, the rise in diabetes & diabetic foot ulcer patients is increasing the demand for wound dressing products.

Moreover, there has been a global increase in the number of traumatic accidents such as burns, gunshots, and road accidents. For instance, according to statistics by the World Health Organization (WHO) in October 2023, approximately 11 million burn cases occurred worldwide, which led to 180,000 deaths globally. Similarly, as per NCBI, every day, more than 30,000 burn cases are registered globally. Therefore, the rising global number of burn cases is anticipated to impel the market over the forecast period.

Wound Dressing Market Report Highlights:

• Based on product, the advanced dressing segment dominated the market in 2023. This can be attributed to globally rising cases of traumatic accidents
• Based on application, the chronic wounds segment dominated the market in 2023
• Based on end-use, the hospital segment dominated the market in 2023. This can be credited to rising surgical procedures and an increasing number of hospitals
• North America dominated the market in 2023. This dominance can be accredited to well-developed healthcare infrastructure, increasing awareness, and the presence of major key players in the region

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Application
  • 1.1.3. End-use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End-use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Wound Dressing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
    • 3.2.1.2. Introduction of innovative and advanced wound products
    • 3.2.1.3. Rising geriatric population
    • 3.2.1.4. Increasing number of ambulatory surgical centers (ASCs)
    • 3.2.1.5. Increasing number of accidents
    • 3.2.1.6. Steep rise in the number of hospitals & urgent care centers and increase in hospital admissions
    • 3.2.1.7. Improvements in public and private hospital infrastructure
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Delayed diagnosis and lower treatment rates in emerging nations
    • 3.2.2.2. High cost of advanced wound care products and chronic wound treatments
    • 3.2.2.3. Stringent manufacturing policies
• 3.3. Wound dressing market analysis tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Wound Dressing Market: Product Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. Advanced dressings
  • 4.1.2. Traditional dressings
• 4.2. Product Market Share, 2023 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Wound Dressing Market by Product Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5.1. Traditional wound dressing
    • 4.5.1.1. Traditional wound dressing market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.2. Gauze
    • 4.5.1.2.1. Gauze market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.3. Tape
    • 4.5.1.3.1. Tape market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.4. Bandages
    • 4.5.1.4.1. Bandages market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.5. Cotton
    • 4.5.1.5.1. Cotton market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.6. Others
    • 4.5.1.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.2. Advanced dressings
    • 4.5.2.1. Advanced dressings market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.2. Moist dressings
    • 4.5.2.2.1. Moist dressings market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.2.2. Foam dressing
    • 4.5.2.2.2.1. Foam dressing market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.2.3. Hydrocolloid dressing
    • 4.5.2.2.3.1. Hydrocolloid dressing market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.2.4. Film dressing
    • 4.5.2.2.4.1. Film dressing market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.2.5. Alginate dressing
    • 4.5.2.2.5.1. Alginate dressing market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.2.6. Hydrogel dressing
    • 4.5.2.2.6.1. Hydrogel dressing market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.2.7. Collagen dressing
    • 4.5.2.2.7.1. Collagen dressing market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.2.8. Other advanced dressing
    • 4.5.2.2.8.1. Other advanced dressing market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.3. Antimicrobial dressings
    • 4.5.2.3.1. Antimicrobial dressings market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.3.2. Silver
    • 4.5.2.3.2.1. Silver market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.3.3. Non-silver
    • 4.5.2.3.3.1. Non-silver market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.4. Active dressings
    • 4.5.2.4.1. Active dressings market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.4.2. Biomaterials
    • 4.5.2.4.2.1. Biomaterials market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.4.3. Skin-substitutes
    • 4.5.2.4.3.1. Skin-substitutes market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Wound dressing Market: Application Estimates & Trend Analysis

• 5.1. Definitions and Scope
  • 5.1.1. Chronic wounds
  • 5.1.2. Acute wounds
• 5.2. Application Market Share, 2023 & 2030
• 5.3. Segment Dashboard
• 5.4. Global Wound Dressing Market by Application Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5.1. Chronic wounds
    • 5.5.1.1. Market estimates and forecast 2018 to 2030 (USD million)
    • 5.5.1.2. Diabetic foot ulcers
    • 5.5.1.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.3. Pressure ulcers
    • 5.5.1.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.4. Venous leg ulcers
    • 5.5.1.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.5. Other chronic wounds
    • 5.5.1.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. Acute wounds
    • 5.5.2.1. Market estimates and forecast 2018 to 2030 (USD million)
    • 5.5.2.2. Surgical & traumatic wounds
    • 5.5.2.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2.3. Burns
    • 5.5.2.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Wound dressing Market: End-use Estimates & Trend Analysis

• 6.1. Definitions and Scope
  • 6.1.1. Hospitals
  • 6.1.2. Outpatient facilities
  • 6.1.3. Home healthcare
  • 6.1.4. Research & manufacturing
• 6.2. End-use Market Share, 2023 & 2030
• 6.3. Segment Dashboard
• 6.4. Global Wound Dressing Market by End-use Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5.1. Hospitals
    • 6.5.1.1. Market estimates and forecast 2018 to 2030 (USD million)
  • 6.5.2. Outpatient facilities
    • 6.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.3. Home healthcare
    • 6.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.4. Research & manufacturing
    • 6.5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Wound dressing Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. market estimates and forecasts, 2018 - 2030
  • 7.5.3. Canada
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada market estimates and forecasts, 2018 - 2030
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Competitive scenario
    • 7.6.1.3. Regulatory framework
    • 7.6.1.4. Reimbursement scenario
    • 7.6.1.5. UK market estimates and forecasts, 2018 - 2030
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Germany market estimates and forecasts, 2018 - 2030
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. France market estimates and forecasts, 2018 - 2030
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Competitive scenario
    • 7.6.4.3. Regulatory framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. Italy market estimates and forecasts, 2018 - 2030
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Competitive scenario
    • 7.6.5.3. Regulatory framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. Spain market estimates and forecasts, 2018 - 2030
  • 7.6.6. Denmark
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Competitive scenario
    • 7.6.6.3. Regulatory framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Denmark market estimates and forecasts, 2018 - 2030
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Competitive scenario
    • 7.6.7.3. Regulatory framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Sweden market estimates and forecasts, 2018 - 2030
  • 7.6.8. Norway
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Competitive scenario
    • 7.6.8.3. Regulatory framework
    • 7.6.8.4. Reimbursement scenario
    • 7.6.8.5. Norway market estimates and forecasts, 2018 - 2030
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Competitive scenario
    • 7.7.1.3. Regulatory framework
    • 7.7.1.4. Reimbursement scenario
    • 7.7.1.5. Japan market estimates and forecasts, 2018 - 2030
  • 7.7.2. India
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. India market estimates and forecasts, 2018 - 2030
  • 7.7.3. China
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. China market estimates and forecasts, 2018 - 2030
  • 7.7.4. South Korea
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. South Korea market estimates and forecasts, 2018 - 2030
  • 7.7.5. Australia
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. Australia market estimates and forecasts, 2018 - 2030
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Competitive scenario
    • 7.7.6.3. Regulatory framework
    • 7.7.6.4. Reimbursement scenario
    • 7.7.6.5. Thailand market estimates and forecasts, 2018 - 2030
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Competitive scenario
    • 7.8.1.3. Regulatory framework
    • 7.8.1.4. Reimbursement scenario
    • 7.8.1.5. Brazil market estimates and forecasts, 2018 - 2030
  • 7.8.2. Mexico
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. Regulatory framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. Mexico market estimates and forecasts, 2018 - 2030
  • 7.8.3. Argentina
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Competitive scenario
    • 7.8.3.3. Regulatory framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Argentina market estimates and forecasts, 2018 - 2030
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Competitive scenario
    • 7.9.1.3. Regulatory framework
    • 7.9.1.4. Reimbursement scenario
    • 7.9.1.5. South Africa market estimates and forecasts, 2018 - 2030
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Competitive scenario
    • 7.9.2.3. Regulatory framework
    • 7.9.2.4. Reimbursement scenario
    • 7.9.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Competitive scenario
    • 7.9.3.3. Regulatory framework
    • 7.9.3.4. Reimbursement scenario
    • 7.9.3.5. UAE market estimates and forecasts, 2018 - 2030
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Competitive scenario
    • 7.9.4.3. Regulatory framework
    • 7.9.4.4. Reimbursement scenario
    • 7.9.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
  • 8.2.1. Innovators
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis
  • 8.3.4. Smith+Nephew
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Molnlycke Health Care AB
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Convatec Group PLC
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Ethicon (Johnson & Johnson)
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. URGO
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Coloplast Corp.
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. 3M
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Integra LifeSciences
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. PAUL HARTMANN AG
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. Dr. Ausbuttel & Co. GmbH
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives
  • 8.3.14. Medline Industries, Inc.
    • 8.3.14.1. Company overview
    • 8.3.14.2. Financial performance
    • 8.3.14.3. Product benchmarking
    • 8.3.14.4. Strategic initiatives
  • 8.3.15. Brightwake Ltd.
    • 8.3.15.1. Company overview
    • 8.3.15.2. Financial performance
    • 8.3.15.3. Product benchmarking
    • 8.3.15.4. Strategic initiatives

관련자료